Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.

Issue 48, 2009
Previous Article Next Article

Novel and emerging approaches for the delivery of metallo-drugs

Author affiliations


Cisplatin and its derivatives are the most widely used clinical anticancer agents. They bring enormous benefits to patients but are also associated with unpleasant side-effects because of their abilities to interact with biomolecules other than the target DNA and their broad tissue toxicity across the body. While two molecular re-designs of cisplatin have entered worldwide clinical use (carboplatin and oxaliplatin) and many more have been trialled, these side effects and drawbacks remain. Recently new strategies have been developed to attempt to decrease these side effects and/or modify the tissue activity spectrum through more localized and effective delivery of the drug to the desired targets. In this review we present an overview of the principal approaches that have been explored, ranging from conjugation to biomolecular vectors or polymers, through pro-drug strategies, to adsorption on ceramic materials and encapsulation in macrocycles, nanotubes and nanocapsules, biomolecules and polymers.

Graphical abstract: Novel and emerging approaches for the delivery of metallo-drugs

Back to tab navigation

Article information

26 Jun 2009
08 Oct 2009
First published
21 Oct 2009

Dalton Trans., 2009, 10702-10711
Article type

Novel and emerging approaches for the delivery of metallo-drugs

C. Sanchez-Cano and M. J. Hannon, Dalton Trans., 2009, 10702
DOI: 10.1039/B912708A

Social activity

Search articles by author